<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We have experienced a case of Type 4 advanced <z:hpo ids='HP_0012126'>gastric cancer</z:hpo> with <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo>, which had been treated with S-1 and intra-peritoneal docetaxcel combination chemotherapy followed by surgery </plain></SENT>
<SENT sid="1" pm="."><plain>Fifteen years ago, a 51-year-old woman was diagnosed as <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> but she ignored any treatment due to no symptoms </plain></SENT>
<SENT sid="2" pm="."><plain>A Type 4 advanced <z:hpo ids='HP_0012126'>gastric cancer</z:hpo> was detected with a chief complaint of stomach heaviness in December 2009 </plain></SENT>
<SENT sid="3" pm="."><plain>Peritoneal lavage cytology was performed before treatment and showed positive peritoneal dissemination </plain></SENT>
<SENT sid="4" pm="."><plain>Two courses of S-1 and intra-peritoneal docetaxcel combination chemotherapy was administered but no serious side effects occurred during the therapy </plain></SENT>
<SENT sid="5" pm="."><plain>Total gastrectomy with D2 lymph node dissection was successfully undergone </plain></SENT>
<SENT sid="6" pm="."><plain>The final stage was ypT4aN3H0M0P1, Stage IV </plain></SENT>
<SENT sid="7" pm="."><plain>It appeared that S-1 and intraperitoneal docetaxcel combination chemotherapy was a safe regimen for a patient with <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> in our case </plain></SENT>
</text></document>